Androgenic screening in men after 50 years with prostate diseases

Автор: Kamalov A.A., Vasilevsky R.P., Okhobotov D.A., Neplokhov E.A.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Андрология

Статья в выпуске: 4, 2018 года.

Бесплатный доступ

Introduction. The Metabolic Syndrome (MS) is the modern pandemic both developed, and developing countries. The MS acts as risk factor of development of cardiovascular accidents, insulin resistance and an hypogonadism. Research objective: searching of correlations of a metabolic syndrome with a syndrome of chronic pelvic pain and violation of a miktion at men. Objective: to develop an algorithm for screening hypogonadism for men undergoing medical examination to detect diseases of the prostate. Materials and methods: the study involved 454 people with various diseases of the prostate gland (benign prostatic hyperplasia, chronic prostatitis, prostate cancer), which are randomly selected for the study during an outpatient admission. In the future, patients underwent a comprehensive urological examination. Hypogonadism was defined as testosterone concentration

Еще

Screening, age-related hypogonadism, testosterone, hormone, prostate gland, male, androgen replacement therapy, urology

Короткий адрес: https://sciup.org/142216912

IDR: 142216912

Статья научная